COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 1512: Articles 15111-15120  | Next

Quantifying the potential for dominant spread of SARS-CoV-2 variant B.1.351 in the United States
Sah, P., Vilches, T. N., Shoukat, A., Pandey, A., Fitzpatrick, M. C., Moghadas, S. M., Galvani, A. P.
10.1101/2021.05.10.21256996 — Posted: 2021-05-12
Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests
Scheiblauer, H., Filomena, A., Nitsche, A., Puyskens, A., Corman, V., Drosten, C., Zwirglmaier, K., Lange, C., Emmerich, P., Mueller, M., Knauer, O., Nuebling, M.
10.1101/2021.05.11.21257016 — Posted: 2021-05-12
Who should get vaccinated first? An effective network information-driven priority vaccination strategy
Liu, D., Tse, C. K., Chan, R. H. M., Zhan, C.
10.1101/2021.05.10.21256999 — Posted: 2021-05-12
Reinfection by the SARS-CoV-2 P.1 variant in blood donors in Manaus, Brazil
Prete, C. A., Buss, L. F., Abrahim, C. M. M., Salomon, T., Crispim, M. A. E., Oikawa, M. K., Buccheri, R., Grebe, E., da Costa, A. G., Fraiji, N. A., Carvalho, M. d. P. S. S., Alexander, N., Faria, N. R., Dye, C., Nascimento, V. H., Busch, M. P., Sabino, E. C.
10.1101/2021.05.10.21256644 — Posted: 2021-05-12
Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
Lapidus, S., Liu, F., Casanovas-Massana, A., Dai, Y., Huck, J. D., Lucas, C., Klein, J., Filler, R. B., Strine, M. S., Sy, M., Deme, A. B., Badiane, A. S., Dieye, B., Ndiaye, I. M., Diedhiou, Y., Mbaye, A. M., Diagne, C. T., Vigan-Womas, I., Mbengue, A., Sadio, B. D., Diagne, M. M., Moore, A. J., Mangou, K., Diallo, F., Sene, S. D., Pouye, M. N., Faye, R., Diouf, B., Nery, N., Costa, F., Reis, M., Muenker, M. C., Hodson, D. Z., Mbarga, Y., Katz, B. Z., Andrews, J. R., Campbell, M., Srivathsan, A., Kamath, K., Baum-Jones, E., Faye, O., Sall, A. A., Velez, J. C. Q., Cappello, M., Wilson, M., Ben-Mamoun, C., Some, F. A., Dabire, R. K., Moukoko, C. E. E., Ouedraogo, J. B., Boum, Y., Shon, J., Ndiaye, D., Wisnewski, A., Parikh, S., Iwasaki, A., Wilen, C. B., Ko, A. I., Ring, A. M., Bei, A. K.
10.1101/2021.05.10.21256855 — Posted: 2021-05-12
A Simple Mathematical Tool to Help Distribute Doses of Two-Dose Covid-19 Vaccines among Non-Immunized and Partly-Immunized Population
Kapoor, A., Kapoor, K. M.
10.1101/2021.05.10.21256978 — Posted: 2021-05-12
Insights into genetic factors contributing to variability in SARS-CoV-2 susceptibility and COVID-19 disease severity
D'Antonio, M., The COVID-19 Host Genetics Initiative, , Arthur, T. D., Nguyen, J. P., Matsui, H., D'Antonio-Chronowska, A., Frazer, K. A.
10.1101/2021.05.10.21256423 — Posted: 2021-05-12
Prevalence and source analysis of COVID-19 misinformation of 138 countries
Al-Zaman, M. S.
10.1101/2021.05.08.21256879 — Posted: 2021-05-12
Fixed dosing of tocilizumab in ICU admitted COVID-19 patients is a superior choice compared to bodyweight based dosing; an observational population pharmacokinetic and pharmacodynamic study
Moes, D. J. A. R., van Westerloo, D. J., Arend, S. M., Swen, J. J., de Vries, A., Guchelaar, H.-J., Joosten, S. A., de Boer, M. G. J., van Gelder, T., van Paassen, J.
10.1101/2021.05.10.21256933 — Posted: 2021-05-12
A model to analyze rideshare data to surveil novel strains of SARS-CoV-2
Safranek, C. W., Scheinker, D.
10.1101/2021.05.07.21256856 — Posted: 2021-05-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).